XOMA Limited (NASDAQ:XOMA)

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

Stocks hit a new high on Monday, and they were indicated to open slightly higher on Tuesday. The Dow is now knocking on 23,000's door, and this bull market is ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

Stocks were indicated to open lower on Monday, but investors know that the major stock indexes remain close to all-time highs. The primary trend that has prevailed for five or ...
Read Full Story »
FDA_logo

10 Major Pharma and FDA Catalysts Coming in December

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades After Election: Ciena, CME Group, Energy Transfer, NVIDIA, US Steel and Many More

Now that the 2016 election is behind us, the market rallied sharply from the lows last week, with the Dow Jones Industrial Average hitting an all-time high. Bond yields are ...
Read Full Story »
Test tubes

5 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, but some had serious falls. In the past year, the health care sector was on fire from positive trials, U.S. ...
Read Full Story »
Sell Button

Insiders Heavily Dump Former High-Flyer Biotech Stock

One thing all biotech investors know is that if a binary event like clinical data goes wrong on a company relying on one specific product, then the end may not ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Boeing, EMC, Hertz, Qualcomm, SanDisk, Twitter, XOMA and More

Stocks were mixed to lower on Thursday morning as investors digesting more and more earnings reports that are hit by soft sales or a strong dollar. Still, the one trend ...
Read Full Story »
Sad lonely pensive old senior woman

Is This the End for XOMA?

XOMA Corp. (NASDAQ: XOMA) stumbled in trading Wednesday morning, perhaps fell off a cliff might be more accurate. In only the first hour of trading alone, over 22 million shares ...
Read Full Story »
research

3 Biotech Stocks With Big Phase 3 Catalyst Data Due in 2015

Whenever the mojo goes out of momentum stocks, whether it is fair or not, biotech usually comes along for the ride. Recently, the biotechs, whether they be large cap industry ...
Read Full Story »
research

3 Biotech Stocks With Upcoming Data That Could Be Huge

Binary events are often the key element in moving a biotech stock higher. Negative binary results or actions can often move shares drastically lower, though. We scan our 24/7 Wall ...
Read Full Story »
Wall Street

Insider Buying Dominates First Full Week of Trading in 2015

Investors saw huge swings in the market for the first week of trading, wild and woolly start to the new year. The steep sell-off at the start of the week ...
Read Full Story »
Wall Street

Insiders Sell High-Profile Stocks as 2014 Trading Comes to an End

It probably would come as no surprise to most stock market watchers that insiders have taken the opportunity this year to take some money off the table during what has ...
Read Full Story »
payoff

Tech Insiders Sell Shares as Markets Hit All-Time Highs

In a week when the markets were putting in some all-time highs, many insiders stayed on the sidelines, which is yet another positive as the bull market looks to continue ...
Read Full Story »
Blue cart

Top Technology and Momentum Stocks Catch Insider Selling

In what is becoming a predictable pattern, despite the sizable market rally this past week, following some serious selling promoted by the plunge in oil price and energy stocks, insider ...
Read Full Story »
170622870

Scorching Hot Biotech Tape: Small-Cap and Mid-Cap Stocks on Fire

The start of 2014 for the small and mid-cap biopharma group has been torrid. Positive exciting catalysts delivering greater-than-expected (or even in-line) results have rapidly pushed selected names higher. The ...
Read Full Story »